AFP and neoplasm: To further substantiate the prognostic power of BMD, we next performed univariate Cox-regression analyses of routinely measured tumor markers for hepatobiliary malignancies (CEA, AFP, Ca19-9) and standard laboratory markers (hemoglobin, leukocyte count, thrombocyte count, sodium, potassium, calcium, AST, bilirubin, GGT, AP, CRP, INR and aPTT), as well as routine clinical and pathological parameters (age, gender, height, weight, BMI).